SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-001462
Filing Date
2023-02-16
Accepted
2023-02-16 17:21:07
Documents
147
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K irwd-20221231x10k.htm   iXBRL 10-K 3237804
2 EX-10.8 irwd-20221231xex10d8.htm EX-10.8 23270
3 EX-23.1 irwd-20221231xex23d1.htm EX-23.1 11734
4 EX-31.1 irwd-20221231xex31d1.htm EX-31.1 13054
5 EX-31.2 irwd-20221231xex31d2.htm EX-31.2 13008
6 EX-32.1 irwd-20221231xex32d1.htm EX-32.1 7486
7 EX-32.2 irwd-20221231xex32d2.htm EX-32.2 7435
8 GRAPHIC irwd-20221231x10k002.jpg GRAPHIC 77847
  Complete submission text file 0001558370-23-001462.txt   15812965

Data Files

Seq Description Document Type Size
9 EX-101.SCH irwd-20221231.xsd EX-101.SCH 106596
10 EX-101.CAL irwd-20221231_cal.xml EX-101.CAL 95467
11 EX-101.DEF irwd-20221231_def.xml EX-101.DEF 504714
12 EX-101.LAB irwd-20221231_lab.xml EX-101.LAB 838679
13 EX-101.PRE irwd-20221231_pre.xml EX-101.PRE 854616
141 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20221231x10k_htm.xml XML 3104368
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34620 | Film No.: 23639423
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences